Meropenem Sun (Meropenem Anhydrous)

Meropenem Sun is a broad‑spectrum carbapenem used for serious bacterial infections that require intravenous therapy.

• Complicated intra‑abdominal infections: provides bacterial eradication and clinical cure.
• Complicated urinary tract infections: eliminates resistant uropathogens and resolves infection.
• Bacterial meningitis: achieves cerebrospinal fluid penetration to treat meningitis pathogens.
• Severe sepsis and septic shock: offers rapid bactericidal activity to control systemic infection.
• Hospital‑acquired and ventilator‑associated pneumonia: targets multidrug‑resistant organisms causing pneumonia.

• Meropenem inhibits bacterial cell wall synthesis by binding to penicillin‑binding proteins (PBPs) across a broad range of Gram‑positive and Gram‑negative organisms. This binding disrupts the final transpeptidation step of peptidoglycan cross‑linking, leading to weakened cell walls, osmotic instability, and ultimately bacterial cell lysis and death.

Adverse reactions may occur with any intravenous antibiotic and should be monitored during therapy.

Common Side Effects

• Nausea: mild to moderate gastrointestinal discomfort.
• Diarrhea: may be watery and occasional.
• Headache: transient and usually resolves.
• Rash: mild erythematous skin changes.
• Elevated liver enzymes: transient increase in hepatic transaminases.
• Phlebitis at infusion site: local irritation.

Serious or Rare Side Effects

• Anaphylaxis: severe allergic reaction requiring immediate medical attention.
• Seizures: especially in patients with renal impairment or high doses.
• Clostridioides difficile colitis: severe diarrhea due to gut flora disruption.
• Renal toxicity: acute kidney injury in susceptible individuals.
• Hemolytic anemia: rare immune‑mediated destruction of red blood cells.

Before initiating Meropenem Sun, clinicians should assess patient history and monitor for potential complications.

• Renal function: adjust dosing in patients with impaired clearance.
• Neurological status: monitor for seizures, particularly in patients with CNS disorders.
• Allergies: avoid in individuals with known carbapenem or beta‑lactam hypersensitivity.
• Pregnancy and lactation: use only if benefits outweigh potential risks, as safety data are limited.
• Drug interactions: review concomitant medications for known interactions.
• Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Meropenem Sun may interact with other agents, influencing efficacy or safety.

Major Interactions (Avoid)

• Valproic acid: increased risk of seizures when combined.
• Aminoglycosides: additive nephrotoxicity; avoid concurrent high‑dose use.

Moderate Interactions (Monitor Closely)

• Loop diuretics: may enhance nephrotoxic potential; monitor renal function.
• Probenecid: can reduce renal clearance of meropenem; adjust dose if needed.
• Anticoagulants (e.g., warfarin): may alter INR; check coagulation parameters regularly.